The potential of Atorvastatin for chronic lung diseases therapy
Atorvastatin (ATO) is of the statin class and is used as an orally administered lipid-lowering drug. ATO is a reversible synthetic competitive inhibitor of 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase thus leading to a reduction in cholesterol synthesis. It has recently been demonstrated that...
| 1. autor: | |
|---|---|
| Format: | Artykuł |
| Język: | English |
| Wydane: |
Elsevier
2020-11-01
|
| Seria: | Saudi Pharmaceutical Journal |
| Hasła przedmiotowe: | |
| Dostęp online: | http://www.sciencedirect.com/science/article/pii/S131901642030205X |